Poliomyelitis Vaccine (live, oral attenuated, Human Diploid Cell), Type 1 and Type 3

[Dosage Form] 

A transparent orange liquid without foreign matter

[Indication] 

It is indicated for prevention against poliomyelitis caused by type 1 and 3 polioviruses for infants above 2 months.

[Specification] 

Each vial contains 0.5ml (5 doses) or 1.0ml (10 doses) . The dosage for one person each time is 2 drops (approximately 0.1ml), in which the total content of live polioviruses should be no less than 6.12 IgCCID501 (type I polioviruses no less than 6.00 IgCCID50 and type III polioviruses no less than 5.50 IgCCID50 respectively). 

[Route of Administration]

Oral taking

[Shelf life]

24 months